A complete application in a minute
Tailored resume and cover letter, ready to send.
Omeros Corporation seeks a Market Development Manager for the South Central region to lead onboarding of healthcare accounts, drive market adoption of complement-inhibitor therapies, and collaborate with Sales, Marketing, and clinical teams.
You will build relationships with academic centers and hospitals, train staff on products, monitor market dynamics, and ensure compliant, strategic launches aligned with company goals.
We are a fast-growing and dynamic organization seeking a Market Development Manager to join our Sales and Marketing team. In this key role, you will be instrumental in driving the commercial success of Omeros’ innovative complement inhibitor therapies. You will lead and manage the onboarding process for a range of accounts - including academic medical centers, community hospitals, and stem cell transplant centers - that will prescribe, dispense, and manage Omeros’ complement inhibitor products.
Omeros is an innovative biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for both large-market and orphan indications, with a focus on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead complement inhibitor YARTEMLEA® (narsoplimab-wuug), which targets the lectin pathway’s effector enzyme MASP-2, is FDA-approved and commercially available in the U.S. for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in adult and pediatric patients aged two years and older. OMS1029, Omeros’ long-acting MASP-2 inhibitor, has successfully completed Phase 1 clinical trials.
Under a recently announced asset purchase and licensing agreement, Novo Nordisk acquired global rights to zaltenibart (formerly OMS906), an inhibitor of MASP-3, the alternative pathway’s key activator, which is in clinical development for PNH and other alternative pathway indications, along with associated intellectual property and related assets. Omeros’ pipeline also includes OMS527, a phosphodiesterase 7 inhibitor in clinical development for cocaine use disorder, which is fully funded by the National Institute on Drug Abuse, and a growing portfolio of novel recombinant antibodies targeting multidrug-resistant organisms and novel molecular and cellular therapeutic programs for oncology. For more information about Omeros and its programs, visit www.omeros.com.
Your responsibilities in this position will include:
Omeros is proud to offer a competitive total compensation package designed to support the lives of our employees and their families. The wage scale for Market Development Manager position is($230,000-$250,000). Salaries will be determined based on knowledge, skills, education, and experience relevant to the role. Employees are offered medical, dental, vision, life insurance, and a 401(k) plan with a company match. Employees accrue three weeks of vacation and 80 hours of sick time on an annual basis and receive twelve paid holidays throughout the calendar year. This position is eligible for incentive and stock options. To learn more about Omeros, please visitwww.omeros.com.
Omeros is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to status as a protected veteran or a qualified individual with a disability, or other protected status such as race, religion, color, national origin, sex, age, marital status, or any other factor determined to be unlawful by federal, state, or local statutes.
It is our policy to provide reasonable accommodation to anyone with a disability who needs assistance completing the job application process. If you need assistance, you can either send an e-mail to hr@omeros.com or contact Omeros, asking for Human Resources, at (206) 676-5000.